Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/UK EMC/Sitagliptin Grindeks 50 mg film-coated tablets

Approved

STANDARD

Sitagliptin Grindeks 50 mg film-coated tablets

Grindeks Kalceks UK🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 957d1d98f121b7f0
Company: Grindeks Kalceks UK
Type: Standard

Approval Details

Approval Id: 957d1d98f121b7f0
Drug Approval Emc Name: Sitagliptin Grindeks 50 mg film-coated tablets
Drug Name: Sitagliptin Grindeks 50 mg film-coated tablets
Company Name: Grindeks Kalceks UK
Company Address: Centrum, Norwich Research Park, Norwich, NR4 7UG, UK
Company Telephone: 01603 320 105
Company Medical Info Direct Line: +371 6708 36 44
Company Medical Info Email: vigilance@grindeks.com
Company Customer Care Direct Line: 01603 320 105
Company Stock Availability: 01603 320 105
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

957d1d98f121b7f0

Type

Standard

Back to UK EMC Approvals

Sitagliptin Grindeks 50 mg film-coated tablets - UK EMC Drug Approval Details